These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 995734)

  • 1. [Heparin effect on total calcium, its fractions and phosphate concentration in healthy subjects and patients with chronic renal failure].
    Grajek S; Raszeja-Wanic B; Smarsz C
    Pol Tyg Lek; 1976 Nov; 31(46):1963-5. PubMed ID: 995734
    [No Abstract]   [Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium in patients on hemodialysis.
    Ring T; Halkier P; Hansen HH; Sanden AK; Nielsen C
    Clin Nephrol; 1995 May; 43(5):332-4. PubMed ID: 7634549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes of serum calcium and serum phosphate level in chronic kidney failure and their significance the diagnosis of hyperparathyroidism].
    Henning HV; Quellhorst E; Wolfram D; Jakob G; Scheler F
    Verh Dtsch Ges Inn Med; 1968; 74():442-5. PubMed ID: 5714362
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of zero magnesium dialysate and magnesium supplements on ionised calcium concentration in patients on regular dialysis treatment.
    Breuer J; Moniz C; Baldwin D; Parsons V
    Nephrol Dial Transplant; 1987; 2(5):347-50. PubMed ID: 3122112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the control of phosphate in the progression of chronic renal failure.
    Barrientos A; Arteaga J; Rodicio JL; Alvarez Ude F; Alcazar JM; Ruilope LM
    Miner Electrolyte Metab; 1982 Mar; 7(3):127-33. PubMed ID: 7169978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the measurement of blood ionized calcium in patients undergoing chronic hemodialysis (author's transl)].
    Imada A; Horiuchi A; Kogi Y; Kawauchi Y
    Rinsho Byori; 1981 Nov; 29(11):1136-40. PubMed ID: 7334668
    [No Abstract]   [Full Text] [Related]  

  • 8. [Calcium and inorganic phosphate fractions in serum in chronic renal failure].
    Raszeja-Wanic B; Gluszek J; Smarsz C
    Pol Arch Med Wewn; 1973 Feb; 50(2):143-50. PubMed ID: 4691763
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative studies of calcium resorption modified by vitamin D2 and D3 in patients with chronic renal failure and dialysis patients].
    Fünfstück R; Günther K; Tietz U; Brandstädt A; Stein G; Hartwich R
    Z Urol Nephrol; 1986 Apr; 79(5):287-94. PubMed ID: 3017021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,3-Biphosphoglycerate, inorganic phosphate, pH and hemoglobin concentration in chronic renal failure of man.
    Gerber G; Holzhütter H; Röseler E; Rapoport I; Elsner R
    Acta Biol Med Ger; 1981; 40(4-5):711-5. PubMed ID: 7032170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum phosphate is an important determinant of corrected serum calcium in end-stage kidney disease.
    Ferrari P; Singer R; Agarwal A; Hurn A; Townsend MA; Chubb P
    Nephrology (Carlton); 2009 Jun; 14(4):383-8. PubMed ID: 19563379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malabsorption of calcium and phosphate in chronic renal failure: 32P and 45Ca studies in dialysis patients.
    Wiegmann TB; Kaye M
    Clin Nephrol; 1990 Jul; 34(1):35-41. PubMed ID: 2387101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of inorganic sulphate in the pathogenesis of hyperparathyroidism in chronic renal failure.
    Michalk D; Tschöpe W; Böhles HJ; Mehls O
    Proc Eur Dial Transplant Assoc; 1981; 18():561-6. PubMed ID: 7329984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of hypophosphatemia in patients on hemodialysis using a calcium-free dialysate with added phosphate.
    Kaye M; Vasilevsky M; Barber E
    Clin Nephrol; 1991 Mar; 35(3):130-3. PubMed ID: 2032398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in the pre-transplant bone-mineral metabolism do not affect the initial progress of the renal graft].
    Rodrigo Calabia E; Ruiz San Millán JC; Gago M; Ruiz Criado J; Piñera Haces C; Fernández Fresnedo G; Palomar R; Gómez Alamillo C; Martín de Francisco AL; Arias M
    Nefrologia; 2009; 29(2):143-9. PubMed ID: 19396320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of calcium carbonate (CaCO3) as phosphate binder in dialysis patients in long-term follow-up over 3 years].
    Sperschneider H; Günther K; Stein G; Marzoll I; Kirchner E
    Z Urol Nephrol; 1990 Aug; 83(8):449-58. PubMed ID: 2122612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a high intake of calcium carbonate in normal subjects and patients with chronic renal failure.
    Clarkson EM; McDonald SJ; De Wardener HE
    Clin Sci; 1966 Jun; 30(3):425-38. PubMed ID: 5914385
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of lowering the serum phosphate on parathyroid hormone secretion and total serum calcium during regular hemodialysis.
    Hill AV; Thein-Than ; Cook DB; Derr KN; Latner AL
    Clin Nephrol; 1973; 1(5):284-9. PubMed ID: 4797465
    [No Abstract]   [Full Text] [Related]  

  • 19. Salivary phosphate secretion in chronic kidney disease.
    Savica V; Calò L; Santoro D; Monardo P; Granata A; Bellinghieri G
    J Ren Nutr; 2008 Jan; 18(1):87-90. PubMed ID: 18089451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hydroxyproline content of plasma of patients with impaired renal function.
    Hart W; Duursma SA; Visser WJ; Njio LK
    Clin Nephrol; 1975; 4(3):104-8. PubMed ID: 1183097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.